A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: Analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review

Clinical and Experimental Rheumatology

Volumn 22, Issue 6, 2004, Pages 749-755

  Geier, Mark R ^a   Geier, David A ^a  

^a MedCon Inc   (United States)

Author keywords

Arthritis; Autoimmunity; Guillain Barr syndrome; Hepatitis B vaccine; Multiple sclerosis; VAERS

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; RECOMBINANT HEPATITIS B VACCINE;

ACUTE GLOMERULONEPHRITIS; ALOPECIA; ANOREXIA; ARTHRALGIA; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BODY WEIGHT DISORDER; CHRONIC DISEASE; CHRONIC GLOMERULONEPHRITIS; DATA BASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ERUPTION; DRUG SURVEILLANCE PROGRAM; ENCEPHALITIS; ENERGIX; EPIDEMIOLOGICAL DATA; ERYTHEMA MULTIFORME; EVIDENCE BASED MEDICINE; EYE DISEASE; EYE PAIN; FATIGUE; GAIT DISORDER; GASTROINTESTINAL DISEASE; GLOMERULONEPHRITIS; GUILLAIN BARRE SYNDROME; HEADACHE; HEPATITIS B; HUMAN; HYPESTHESIA; INFLUENZA; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MONOZYGOTIC TWINS; MORNING STIFFNESS; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; MYALGIA; MYELITIS; NEUROLOGIC DISEASE; NEUROPATHY; OPTIC NERVE DISEASE; OSTEOARTHRITIS; PANCYTOPENIA; PERSONALITY DISORDER; PITYRIASIS ROSEA; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RENOVASCULAR DISEASE; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SENSORY DYSFUNCTION; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA; TREMOR; VACCINATION; WEIGHT REDUCTION; WRIST DISEASE;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; DATABASES, FACTUAL; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; RISK FACTORS; TWINS, MONOZYGOTIC;

EID: 11044229592     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. EMINI EA, ELLIS RW, MILLER WJ, McALEER WJ, SCOLNICK EM, GERETY RJ: Production and immunological analysis of recombinant hepatitis B vaccine. J Infect 1986; 13 (Suppl. A): 3-9.
2. STEPHENNE J: Development and production aspects of a recombinant yeast-derived hepatitis B vaccine. Vaccine 1990; 8 (Suppl.): S69-73.
3. ROGERSON SJ, NYE FJ: Hepatitis B vaccine associated with erythema nodosum and polyarthritis. BMJ 1990; 301: 345.
4. GROSS K, COMBE C, KRUGER K, SCHATTENKIRCHNER M: Arthritis after hepatitis B vaccination. Report of three cases. Scand J Rheumatol 1995; 24: 50-2.
5. BRACCI M, ZOPPINI A: Polyarthritis associated with hepatitis B vaccination. Br J Rheumatol 1997; 36: 300-1.
6. CATHEBRAS P, CARTRY O, PROUST MH et al.: Arthritis, hypercalcemia, and lytic bone lesions after hepatitis B vaccination. J Rheumatol 1996; 23: 558-60.
7. HASSAN W, OLDHAM R: Reiter's syndrome and reactive arthritis in health care workers after vaccination. BMJ 1994; 309: 94.
8. MAILLEFERT IF, SIBILIA J, TOUSSIROT E et al.: Rheumatic disorders developed after hepatitis B vaccination. Rheumatology 1999; 38: 978-83.
9. VAUTIER G, CARTY JE: Acute sero-positive rheumatoid arthritis occurring after hepatitis vaccination. Br J Rheumatol 1994; 33: 991.
10. GEIER MR, GEIER DA, ZAHALSKY AC: A review of hepatitis B vaccination. Expert Opin Drug Saf 2003; 2: 113-22.
11. POPE JE, STEVENS A, HOWSON W, BELL DA: The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998; 25: 1687-93.
12. TUDELA P, MARTI S, BONAL J: Systemic lupus erythematosus and vaccination against hepatitis B. Nephron 1992; 62: 236.
13. GUISERIX J: Systemic lupus erythematosus following hepatitis B vaccine. Nephron 1996; 74: 441.
14. ALBITAR S, BOURGEON B, GENIN R et al.: Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrol Dial Transplant 1997; 12: 2169-70.
15. STEWART O, CHANG B, BRADBURY J: Simultaneous administration of hepatitis B and polio vaccines associated with bilateral optic neuritis. Br J Ophthalmol 1999; 83: 1200-1.
16. SINDERN E, SCHRODER JM, KRISMANN M, MALIN JP: Inflammatory polyradiculoneuropathy with spinal cord involvement and lethal outcome after hepatitis B vaccination. J Neurol Sci 2001; 186: 81-5.
17. VITAL C, VITALA, GBIKPI-BENISSAN G et al.: Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases. J Peripher Nerv Syst 2002; 7: 163-7.
18. SINSAWAIWONG S, THAMPANITCHAWONG P: Guillain-Barre' syndrome following recombinant hepatitis B vaccine and literature review. J Med Assoc Thai 2000; 83: 1124-6.
19. CREANGE A, TEMAM G, LEFAUCHEUR JP: Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity 1999; 30: 143-6.
20. TUOHY PG: Guillain-Barre syndrome following immunization with synthetic hepatitis B vaccine. NZ Med J 1989; 102: 114-5.
21. CARMELI Y, OREN R: Hepatitis B vaccine side-effect. Lancet 1993; 341: 250-1.
22. MACARIO F, FREITAS L, CORREIA J, CAMPOS M, MARQUES A: Nephrotic syndrome after recombinant hepatitis B vaccine. Clin Nephrol 1995; 43: 349.
23. ISLEK 1, CENGIZ K, CAKIR M, KUCUKODUK S: Nephrotic syndrome following hepatitis B vaccination. Pediatr Nephrol 2000; 14: 89-90.
24. POULLIN P, GABRIEL B: Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet 1994; 344: 1293.
25. VIALLARD JF, BOIRON JM, PARRENS M et al.: Severe pancytopenia triggered by recombinant hepatitis B vaccine. Br J Haematol 2000; 110: 230-3.
26. NEAU D, BONNET F, MICHAUD M et al.: Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases. Scand J Infect Dis 1998; 30: 115-8.
27. TARTAGLINO LM, HEIMAN-PATTERSON T, FRIEDMAN DP, FLANDERS AE: MR imaging in a case of post vaccination myelitis. Am J Neuroradiol 1995; 16: 581-2.
28. TREVISANI F, GATTINARA GC, CARACENI P et al.: Transverse myelitis following hepatitis B vaccination. J Hepatol 1993; 19: 317-8.
29. INIGUEZ C, MAURI JA, LARRODE P, LOPEZ del VAL J, JERICO I, MORALES F: Acute transverse myelitis secondary to hepatitis B vaccination. Rev Neurol 2000; 31: 430-2.
30. MAHASSIN F, ALGAYRES JP, VALMARY J et al.: Acute myelitis after vaccination against hepatitis B. Presse Med 1993; 22: 1997-8.
31. KARAALI-SAVRUN F, ALTINTAS A, SAIP S, SIVA A: Hepatitis B vaccine related-myelitis ? Eur J Neurol 2001; 8: 711-5.
32. SONG HK, KIM HC, YUN YH: Acute myelitis after hepatitis B vaccination. J Korean Med Sci 1997; 12: 249-51.
33. MEYBOOM RH, FUCIK H, EDWARDS IR: Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet 1995; 345: 1638.
34. ZAAS A, SCHEEL P, VENBRUX A, HELLMANN DB: Larger artery vasculitis following recombinant hepatitis B vaccination: 2 cases. J Rheumatol 2001; 28: 1116-20.
35. KEYSER FD, NAEYAERT JM, HINDRYCKX P et al.: Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol 2000; 18: 81-5.
36. Le HELLO C, COHEN P, BOUSSER M, LETELLIER P, GUILLEVIN L: Suspected hepatitis B vaccination related vasculitis. J Rheumatol 1999; 26: 191-4.
37. PENNESI M, TORRE G, DEL SANTO M, SONZOGNI A: Glomerulonephritis after recombinant hepatitis B vaccine. Pediatr Infect Dis 2002; 21: 172-3.
38. KONSTANTINOU D, PASCHALIS C, MARAZIOTIS T, DIMOPOULOS P, BASSARIS H, SKOUTELIS A: Two episodes of leukoencephalitis associated with recombinant hepatitis B vaccination in a single patient. CID 2001; 33: 1772-3.
39. PANDE H, LACY BE, CROWELL MD: Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci 2002; 47: 2664-8.
40. HASSAN W, OLDHAM R: Reiter's syndrome and reactive arthritis in health care worked after vaccination. BMJ 1994; 309: 94-5.
41. MAILLEFERT JF, SIBILIA J, TOUSSIROT E et al.: Rheuamtic diseases developed after hepatitis B vaccination. Rheumatology 1999; 38: 978-83.
42. TARTAGLINO LM, HEIMAN-PATTERSON T, FRIEDMAN DP, FLANDERS AE: MR imaging in a case of post-vaccination myelitis. AJNR 1995; 16: 581-2.
43. POPE JE, STEVENS A, HOWSON W, BELL DA: The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998; 25: 1687-93.
44. GUIS S, JATTEI JP, NICOLI F et al.: Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants ? Arthritis Rheum 2002; 47: 543-5.
45. McMAHON BJ, HELMINIAK C, WAINWRIGHT RB, BULKOW L, TRIMBLE BA, WAINWRIGHT K: Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1992; 92: 254-6.
46. RIETSCHEL RL, ADAMS RM: Reactions to thimerosal in hepatitis B vaccines. Dermatol Clin 1990; 8: 161-4.
47. GEIER MR, GEIER DA: Hepatitis B vaccination safety. Ann Pharmacother 2002; 36: 370-4.
48. DeSTEFANO F, VERSTRAETEN T, JACKSON LA et al.: Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003; 60: 504-9.
49. SHOENFELD Y, AHARON-MAOR A, SHERER Y: Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol 2000; 18: 181-4.
50. PIRMOHAMED M, WINSTANLEY P: Hepatitis B vaccine and neurotoxicity. Postgrad Med J 1997; 73: 462-3.